Buch, Englisch, 124 Seiten, Format (B × H): 138 mm x 216 mm
Federal Policy Dynamics and the Pharmaceutical Industry
Buch, Englisch, 124 Seiten, Format (B × H): 138 mm x 216 mm
ISBN: 978-1-041-15981-0
Verlag: CRC Press
The US pharmaceutical landscape is in the midst of impactful shifts. A series of ambitious, aggressive, and often interconnected federal policy changes—from direct drug price controls and sweeping Pharmacy Benefit Manager reforms to strategic initiatives to reshore manufacturing and rapidly evolving FDA approaches—is creating a new reality for industry leaders, innovators, and strategists. In this analysis, a federal policy expert unpacks the complex forces reshaping how life-saving therapies are researched, developed, manufactured, and delivered.
Key Features
•Understand the Interconnectedness of U.S. Federal Policies.
•Analyze the Strategic Impacts of Key Legislation and Executive Actions.
•Evaluate Challenges and Opportunities in a Dynamic Regulatory Environment.
•Analyze the Interplay of U.S. Federal Actions and Industry Operations.
•Formulate Adaptive Strategies for Industry Resilience.
Zielgruppe
Academic, Postgraduate, Professional Practice & Development, and Professional Reference
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pharmakologie, Toxikologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Pharmazie
- Technische Wissenschaften Verfahrenstechnik | Chemieingenieurwesen | Biotechnologie Pharmazeutische Technologie
- Wirtschaftswissenschaften Wirtschaftssektoren & Branchen Fertigungsindustrie Pharmaindustrie
Weitere Infos & Material
Chapter 1: Introduction – Adapting to Change. Chapter 2: Key Forces Impacting Pharma. Chapter 3: Additional Emerging Policy Dynamics. Chapter 4: Small Businesses in the New Pharma Paradigm. Chapter 5: Impact of/on Compounding Pharmacies. Chapter 6: The Most Favored Nation (MFN) Drug Pricing Executive Order. Chapter 7: Medicare Part B vs. Part D Drug Coverage. Chapter 8: International Impacts on Pharma. Chapter 9: Strategic Recommendations for the Pharmaceutical Industry. Chapter 10: Conclusion – Forging the Future – Resilience and Value in Pharma's New Era.